The company will not receive any proceeds from the sale of the shares offered by this prospectus. Don't Miss Our End of Quarter Offers: ...

New option listings for March 19th include Colombier Acquisition Corp II (CLBR), Danimer Scientific, Inc. (DNMRQ), Kalaris Therapeutic Inc.

Company reports financial results for the fourth quarter and full-year 2024, and will host a conference call tomorrow, March 19 at 8:30 am ET The three assets in the portfolio are in-licensed from ...

including the pending sale of Aadi Sub to Kaken and the payment of the upfront and early milestones under the Wuxi ADC agreement; the anticipated timing of the Company's development of its ...

Aadi is a precision oncology company with a vision to make bold choices in applying technology to efficiently deliver improved precision oncology therapies for people living with difficult-to ...

From its origins in a garage to becoming one of the most recognisable symbols in the world, explore the story behind the iconic Apple logo design. Apple is a company that has changed the technology ...